Our findings suggest that cryptotanshinone may exert anti-tumor effects by modulating the IL-17 pathway, potentially inhibiting cancer cell growth and metastasis through the regulation of IL-17 expression and its downstream signals. This evidence concerns the gene IL17A and neoplasm.